Abstract
Leishmaniasis is a neglected disease with a broad clinical spectrum which includes asymptomatic infection. A thorough diagnosis, able to distinguish and quantify Leishmania parasites in a clinical sample, constitutes a key step in choosing an appropriate therapy, making an accurate prognosis and performing epidemiological studies. Several molecular techniques have been shown to be effective in the diagnosis of leishmaniasis. In particular, a number of PCR methods have been developed on various target DNA sequences including kinetoplast minicircle constant regions. The first aim of this study was to develop a SYBR green-based qPCR assay for Leishmania (Leishmania) infantum detection and quantification, using kinetoplast minicircle constant region as target. To this end, two assays were compared: the first used previously published primer pairs (qPCR1), whereas the second used a nested primer pairs generating a shorter PCR product (qPCR2). The second aim of this study was to evaluate the possibility to discriminate among subgenera Leishmania (Leishmania) and Leishmania (Viannia) using the qPCR2 assay followed by melting or High Resolution Melt (HRM) analysis. Both assays used in this study showed good sensitivity and specificity, and a good correlation with standard IFAT methods in 62 canine clinical samples. However, the qPCR2 assay allowed to discriminate between Leishmania (Leishmania) and Leishmania (Viannia) subgenera through melting or HRM analysis. In addition to developing assays, we investigated the number and genetic variability of kinetoplast minicircles in the Leishmania (L.) infantum WHO international reference strain (MHOM/TN/80/IPT1), highlighting the presence of minicircle subclasses and sequence heterogeneity. Specifically, the kinetoplast minicircle number per cell was estimated to be 26,566±1,192, while the subclass of minicircles amplifiable by qPCR2 was estimated to be 1,263±115. This heterogeneity, also observed in canine clinical samples, must be taken into account in quantitative PCR-based applications; however, it might also be used to differentiate between Leishmania subgenera.
Highlights
Leishmaniasis is a neglected disease of the Old and New Worlds with a broad clinical spectrum encompassing asymptomatic infection and three main clinical syndromes: visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucosal leishmaniasis (ML)
Leishmania donovani complex belongs to the subgenus Leishmania (Leishmania) and it is the etiological agent of VL, while the species belonging to the subgenus Leishmania (Viannia) are the etiological agents of CL and ML
QPCR conditions with SYBR green were optimized with MaryF-MaryR and MLF-MLR primers: the results showed specific amplicons having melting temperatures of about 87uC and 85uC, respectively, without non-specific products or primer dimers (Fig. S1)
Summary
Leishmaniasis is a neglected disease of the Old and New Worlds with a broad clinical spectrum encompassing asymptomatic infection and three main clinical syndromes: visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucosal leishmaniasis (ML). At least 15 Leishmania species are pathogenic for Homo sapiens. They are primarily transmitted by phlebotomine sandflies, infection may occur sporadically through blood transfusion, contaminated needles, and organ transplantation [1]. The leishmaniasis is still a public health problem in 98 countries, affecting both rural and urban areas. Worldwide there are an estimated 0.2–0.4 million new cases of VL and 0.7–1.2 million new cases of CL annually, while 12 million people are currently affected by the disease [2]. The VL mortality is second only to malaria among parasitic diseases [3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
